Your browser doesn't support javascript.
loading
De novo mutations in HCN1 cause early infantile epileptic encephalopathy.
Nava, Caroline; Dalle, Carine; Rastetter, Agnès; Striano, Pasquale; de Kovel, Carolien G F; Nabbout, Rima; Cancès, Claude; Ville, Dorothée; Brilstra, Eva H; Gobbi, Giuseppe; Raffo, Emmanuel; Bouteiller, Delphine; Marie, Yannick; Trouillard, Oriane; Robbiano, Angela; Keren, Boris; Agher, Dahbia; Roze, Emmanuel; Lesage, Suzanne; Nicolas, Aude; Brice, Alexis; Baulac, Michel; Vogt, Cornelia; El Hajj, Nady; Schneider, Eberhard; Suls, Arvid; Weckhuysen, Sarah; Gormley, Padhraig; Lehesjoki, Anna-Elina; De Jonghe, Peter; Helbig, Ingo; Baulac, Stéphanie; Zara, Federico; Koeleman, Bobby P C; Haaf, Thomas; LeGuern, Eric; Depienne, Christel.
Afiliação
  • Nava C; 1] INSERM UMR 975, Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, Paris, France. [2] CNRS 7225, Hôpital Pitié-Salpêtrière, Paris, France. [3] Université Pierre et Marie Curie-Paris 6 (UPMC), UMRS 975, Paris, France. [4] Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital
  • Dalle C; 1] INSERM UMR 975, Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, Paris, France. [2] Institut du Cerveau et de la Moelle Epinière, Plateforme d'Electrophysiologie, Paris, France. [3].
  • Rastetter A; INSERM UMR 975, Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, Paris, France.
  • Striano P; Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, 'G Gaslini Institute', Genova, Italy.
  • de Kovel CG; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Nabbout R; 1] Department of Pediatric Neurology, Centre de Référence Epilepsies Rares, Hôpital Necker-Enfants Malades, AP-HP, Paris, France. [2] INSERM U663, Université Paris Descartes, Sorbonne Paris Cité, Hôpital Necker-Enfants Malades, Paris, France.
  • Cancès C; Service de Neurologie Pédiatrique, Hôpital des Enfants, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • Ville D; Service de Neurologie Pédiatrique, Hôpital Femme Mère Enfant, Centre Hospitalier Universitaire de Lyon, Bron, France.
  • Brilstra EH; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Gobbi G; Child Neurology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Institute of Neurological Sciences of Bologna, Bologna, Italy.
  • Raffo E; Service de Neuropédiatrie, Hôpital d'Enfants de Brabois, Centre Hospitalier Universitaire de Nancy, Vandoeuvre Les Nancy, France.
  • Bouteiller D; Institut du Cerveau et de la Moelle Epinière, Plateforme de Génotypage et Séquençage, Paris, France.
  • Marie Y; Institut du Cerveau et de la Moelle Epinière, Plateforme de Génotypage et Séquençage, Paris, France.
  • Trouillard O; 1] INSERM UMR 975, Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, Paris, France. [2] Université Pierre et Marie Curie-Paris 6 (UPMC), UMRS 975, Paris, France. [3] Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Département de Génétique et de Cytogé
  • Robbiano A; Laboratory of Neurogenetics, Department of Neurosciences, Gaslini Institute, Genova, Italy.
  • Keren B; AP-HP, Hôpital Pitié-Salpêtrière, Département de Génétique et de Cytogénétique, Unité Fonctionnelle de Cytogénétique, Paris, France.
  • Agher D; INSERM UMR 975, Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, Paris, France.
  • Roze E; 1] INSERM UMR 975, Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, Paris, France. [2] CNRS 7225, Hôpital Pitié-Salpêtrière, Paris, France. [3] Université Pierre et Marie Curie-Paris 6 (UPMC), UMRS 975, Paris, France.
  • Lesage S; 1] INSERM UMR 975, Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, Paris, France. [2] CNRS 7225, Hôpital Pitié-Salpêtrière, Paris, France. [3] Université Pierre et Marie Curie-Paris 6 (UPMC), UMRS 975, Paris, France.
  • Nicolas A; 1] INSERM UMR 975, Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, Paris, France. [2] CNRS 7225, Hôpital Pitié-Salpêtrière, Paris, France. [3] Université Pierre et Marie Curie-Paris 6 (UPMC), UMRS 975, Paris, France.
  • Brice A; 1] INSERM UMR 975, Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, Paris, France. [2] CNRS 7225, Hôpital Pitié-Salpêtrière, Paris, France. [3] Université Pierre et Marie Curie-Paris 6 (UPMC), UMRS 975, Paris, France. [4] Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital
  • Baulac M; 1] INSERM UMR 975, Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, Paris, France. [2] CNRS 7225, Hôpital Pitié-Salpêtrière, Paris, France. [3] Université Pierre et Marie Curie-Paris 6 (UPMC), UMRS 975, Paris, France.
  • Vogt C; Institüt für Humangenetik, Universität Würzburg, Würzburg, Germany.
  • El Hajj N; Institüt für Humangenetik, Universität Würzburg, Würzburg, Germany.
  • Schneider E; Institüt für Humangenetik, Universität Würzburg, Würzburg, Germany.
  • Suls A; 1] Neurogenetics Group, Department of Molecular Genetics, VIB, Antwerp, Belgium. [2] Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Weckhuysen S; 1] Neurogenetics Group, Department of Molecular Genetics, VIB, Antwerp, Belgium. [2] Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Gormley P; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • Lehesjoki AE; 1] Folkhälsan Institute of Genetics, Helsinki, Finland. [2] Research Programs Unit, Molecular Neurology and Neuroscience Center, University of Helsinki, Helsinki, Finland.
  • De Jonghe P; 1] Neurogenetics Group, Department of Molecular Genetics, VIB, Antwerp, Belgium. [2] Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Helbig I; Department of Neuropediatrics, University Medical Center Schleswig-Holstein, Christian Albrechts University, Kiel, Germany.
  • Baulac S; 1] INSERM UMR 975, Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, Paris, France. [2] CNRS 7225, Hôpital Pitié-Salpêtrière, Paris, France. [3] Université Pierre et Marie Curie-Paris 6 (UPMC), UMRS 975, Paris, France.
  • Zara F; Laboratory of Neurogenetics, Department of Neurosciences, Gaslini Institute, Genova, Italy.
  • Koeleman BP; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Haaf T; Institüt für Humangenetik, Universität Würzburg, Würzburg, Germany.
  • LeGuern E; 1] INSERM UMR 975, Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, Paris, France. [2] CNRS 7225, Hôpital Pitié-Salpêtrière, Paris, France. [3] Université Pierre et Marie Curie-Paris 6 (UPMC), UMRS 975, Paris, France. [4] Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital
  • Depienne C; 1] INSERM UMR 975, Institut du Cerveau et de la Moelle Epinière, Hôpital Pitié-Salpêtrière, Paris, France. [2] Université Pierre et Marie Curie-Paris 6 (UPMC), UMRS 975, Paris, France. [3] Institüt für Humangenetik, Universität Würzburg, Würzburg, Germany.
Nat Genet ; 46(6): 640-5, 2014 Jun.
Article em En | MEDLINE | ID: mdl-24747641
ABSTRACT
Hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels contribute to cationic Ih current in neurons and regulate the excitability of neuronal networks. Studies in rat models have shown that the Hcn1 gene has a key role in epilepsy, but clinical evidence implicating HCN1 mutations in human epilepsy is lacking. We carried out exome sequencing for parent-offspring trios with fever-sensitive, intractable epileptic encephalopathy, leading to the discovery of two de novo missense HCN1 mutations. Screening of follow-up cohorts comprising 157 cases in total identified 4 additional amino acid substitutions. Patch-clamp recordings of Ih currents in cells expressing wild-type or mutant human HCN1 channels showed that the mutations had striking but divergent effects on homomeric channels. Individuals with mutations had clinical features resembling those of Dravet syndrome with progression toward atypical absences, intellectual disability and autistic traits. These findings provide clear evidence that de novo HCN1 point mutations cause a recognizable early-onset epileptic encephalopathy in humans.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espasmos Infantis / Canais de Potássio / Mutação Puntual / Síndrome de Aicardi / Canais Disparados por Nucleotídeos Cíclicos Ativados por Hiperpolarização Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espasmos Infantis / Canais de Potássio / Mutação Puntual / Síndrome de Aicardi / Canais Disparados por Nucleotídeos Cíclicos Ativados por Hiperpolarização Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article